I see your point. I think within a couple weeks we'll be putting shorts in an even harder position. The bs they are spewing holds nothing valid. Fundamentals continue to escalate. Leo is coming through for us. I also completely understand the frustration many have expressed, including Drano. I have seen many tactics over the years of malicious shorting holding back a company. They've messed with the wrong company this time. There are no funding issues and science is proving to move forward. Not to mention the completely non toxic arrangements Cellceutix has access to through 2016. Companies I've seen drug through similar short attacks that drag on end up succumbing to very dilutive financing and just can't recover. This is in no way happening here. The more vigilant we can be in fighting fire with fire is to stay the course and reply with fact after fact straight from the company staying on topic. We know what we own.
I am invested in another company that has one of the highest short interest ratios, NAVB. Over 30M shares short with around 55 days to cover. How does that happen? Hedge funds that have the capital not to sweat a share price fluctuation of even $1. Fortunately for me this one has been one of my best bottom plays but similarly to Cellceutix, there are many that bought higher and find their due diligence tested to the limits.
We can't ignore what people say about shorts, we can simply rub facts in their face for as long as it takes. Stay on topic, keep it about the company.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links